Literature DB >> 10895015

Is one set of sextant biopsies enough to rule out prostate Cancer? Influence of transition and total prostate volumes on prostate cancer yield.

B Djavan1, A R Zlotta, S Ekane, M Remzi, G Kramer, T Roumeguère, M Etemad, R Wolfram, C C Schulman, M Marberger.   

Abstract

PURPOSE: Although the sextant biopsy technique has been widely used, concern has arisen that this method may not include an adequate sampling of the prostate, especially for large prostate volumes. We conducted a multicenter study in patients with PSA levels <10 ng/ml to determine the influence of the total and transition zone (TZ) volumes of the prostate for predicting whether one single set of biopsies was sufficient to rule out prostate cancer (PCa). These parameters were evaluated in patients in whom PCa was found after one set of systematic sextant biopsies and those in whom PCa was found after a repeat biopsy.
MATERIALS AND METHODS: A total of 1,018 patients were included in this study. All underwent transrectal ultrasound-guided needle sextant and two TZ biopsies of the prostate. Total and TZ volumes of the prostate were measured (prolate ellipsoid method). From this cohort, all patients in whom a benign disease was found after the first set of biopsies underwent a second similar set of biopsies within 6 weeks. Only patients with PCa were included in this study, whether diagnosed on first or repeat biopsy. Uni- and multivariate statistical analysis using the SAS system (Cary, N.C., USA) and ROC curves were used to compare patients in whom the diagnosis was performed after the first set of biopsies and those who required a second set.
RESULTS: Of the 1,018 patients, 344 (33.8%) had PCa diagnosed, 285 (28%) after the first set of biopsies, and 59 (8.1%) on repeat biopsy. As compared to patients diagnosed with PCa after the first set of biopsies, patients diagnosed after the second set had larger total prostate and TZ volumes (43.1+/-13.0 vs. 32.5+/-10.6 cm(3), p<0.0001 and 20.5+/-8.3 vs. 12.8+/-6.0 cm(3), p<0.0001). ROC curves showed that total and TZ volumes of 45 and 22. 5 cm(3), respectively, provided the best combination of sensitivity and specificity for discriminating between patients diagnosed with PCa after the first from those diagnosed after a second set.
CONCLUSION: In patients with total prostate volume >45 cm(3) and TZ >22.5 cm(3), a single set of sextant biopsies may not be sufficient to rule out PCa. In these patients, a repeat biopsy should be considered in case of a negative first biopsy.

Entities:  

Mesh:

Year:  2000        PMID: 10895015     DOI: 10.1159/000020282

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  7 in total

1.  Prostate-specific antigen testing. Should we recommend it?

Authors:  John Hickey
Journal:  Can Fam Physician       Date:  2003-03       Impact factor: 3.275

2.  The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial.

Authors:  Maria Frånlund; Sigrid Carlsson; Johan Stranne; Gunnar Aus; Jonas Hugosson
Journal:  BJU Int       Date:  2012-04-30       Impact factor: 5.588

Review 3.  Biopsy standards for detection of prostate cancer.

Authors:  Bob Djavan; Markus Margreiter
Journal:  World J Urol       Date:  2007-03-07       Impact factor: 4.226

4.  The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.

Authors:  Floyd J Fowler; Michael J Barry; Beth Walker-Corkery; Jean-Francois Caubet; David W Bates; Jeong Min Lee; Alison Hauser; Mary McNaughton-Collins
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

5.  Concordance between transrectal ultrasound guided biopsy results and radical prostatectomy final pathology: Are we getting better at predicting final pathology?

Authors:  Richard Walker; Uri Lindner; Alyssa Louis; Robin Kalnin; Marguerite Ennis; Michael Nesbitt; Theodorus H van der Kwast; Antonio Finelli; Neil E Fleshner; Alexandre R Zlotta; Michael A S Jewett; Robert Hamilton; Girish Kulkarni; John Trachtenberg
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

6.  Significance of atypical small acinar proliferation and high-grade prostatic intraepithelial neoplasia in prostate biopsy.

Authors:  Orhan Koca; Selahattin Calışkan; Metin İshak Oztürk; Mustafa Güneş; M Ihsan Karaman
Journal:  Korean J Urol       Date:  2011-11-17

7.  Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy.

Authors:  Gan-Sheng Xie; Jin-Xing Lyv; Gang Li; Chun-Yin Yan; Jian-Quan Hou; Jin-Xian Pu; Xiang Ding; Yu-Hua Huang
Journal:  Chin Med J (Engl)       Date:  2016-08-05       Impact factor: 2.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.